SIX1 Overexpression in Diffuse-type and Grade III Gastric Tumors: Features That Are Associated with Poor Prognosis

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2015 Sep 1

PMID 26322287

Citations 9

Authors

Modjtaba Emadi-Baygi

Parvaneh Nikpour

Elaheh Emadi-Andani

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer is the second most common cancer worldwide. In Iran, the incidence of gastric cancer is well above the world average, and is the first common cancer in Iranian men and the third one in women. Located at chromosome 14q23, SIX1 is a homolog of the Drosophila 'sine oculis' (so) gene and is highly conserved in numerous species. In addition to the role of SIX1 in the development, its expression is frequently dysregulated in multiple cancers. This study aimed to evaluate the clinicopathological features of the expression of SIX1 gene in gastric adenocarcinoma.

Materials And Methods: Thirty pairs of gastric tissue samples from patients with gastric adenocarcinoma were evaluated for SIX1 gene expression using quantitative real-time polymerase chain reaction. A paired t-test or one-way ANOVA with post hoc multiple comparisons were used to analyze the differences between groups. Statistical significance was defined as P ≤ 0.05.

Results: SIX1 expression was decreased in tumoral samples. However, its expression increased significantly in diffuse-type gastric cancer. Furthermore, there was a trend toward statistical significance in increasing SIX1 gene expression with higher grades. Of note, the difference was significant between grades I and III.

Conclusions: The results suggest that SIX1 gene expression might be used in the future as a potential biomarker to predict the outcome of the disease as diffuse-type and grade III of gastric tumors are associated with poor prognosis.

Citing Articles

Introduction of as a potential diagnostic and prognostic biomarker for gastric cancer via integrative bioinformatics analysis of a competing endogenous RNA network and experimental validation.

Daneshmand-Parsa M, Nikpour P Iran J Basic Med Sci. 2024; 27(11):1456-1463.

PMID: 39386228 PMC: 11459342. DOI: 10.22038/ijbms.2024.74686.16216.

Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics.

Bian Z, Benjamin M, Bialousow L, Tian Y, Hobbs G, Karan D Heliyon. 2024; 10(12):e33204.

PMID: 39022099 PMC: 11252760. DOI: 10.1016/j.heliyon.2024.e33204.

All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.

Hughes C, Alderman C, Wolin A, Fields K, Zhao R, Ford H Biochim Biophys Acta Rev Cancer. 2024; 1879(3):189098.

PMID: 38555001 PMC: 11111358. DOI: 10.1016/j.bbcan.2024.189098.

Ginsenoside Rh4 Suppresses Metastasis of Gastric Cancer via SIX1-Dependent TGF-β/Smad2/3 Signaling Pathway.

Jiang H, Ma P, Duan Z, Liu Y, Shen S, Mi Y Nutrients. 2022; 14(8).

PMID: 35458126 PMC: 9032069. DOI: 10.3390/nu14081564.

Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues.

Ghasemi S, Emadi-Baygi M, Nikpour P Turk J Med Sci. 2019; 49(2):687-695.

PMID: 30866608 PMC: 7018364. DOI: 10.3906/sag-1806-50.

References

Gumus-Akay G, Unal A, Elhan A, Bayar S, Karadayt K, Sunguroglu A . DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey. Arch Med Res. 2010; 40(7):551-60. DOI: 10.1016/j.arcmed.2009.07.004. View

Behbakht K, Qamar L, Aldridge C, Coletta R, Davidson S, Thorburn A . Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res. 2007; 67(7):3036-42. DOI: 10.1158/0008-5472.CAN-06-3755. View

Nikpour P, Baygi M, Steinhoff C, Hader C, Luca A, Mowla S . The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. J Cell Mol Med. 2010; 15(5):1210-24. PMC: 3822633. DOI: 10.1111/j.1582-4934.2010.01090.x. View

Yu Y, Khan J, Khanna C, Helman L, Meltzer P, Merlino G . Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004; 10(2):175-81. DOI: 10.1038/nm966. View

Ng K, Man K, Sun C, Lee T, Poon R, Lo C . Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer. 2006; 95(8):1050-5. PMC: 2360701. DOI: 10.1038/sj.bjc.6603399. View

Malekzadeh R, Derakhshan M, Malekzadeh Z . Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12(6):576-83. View

TANNER M, Karhu R, Nupponen N, Borg A, Baldetorp B, Pejovic T . Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol. 1998; 153(1):191-9. PMC: 1852954. DOI: 10.1016/S0002-9440(10)65560-5. View

Li C, Guo M, Borczuk A, Powell C, Wei M, Thaker H . Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol. 2002; 160(6):2181-90. PMC: 1850829. DOI: 10.1016/S0002-9440(10)61166-2. View

Gomceli I, Demiriz B, Tez M . Gastric carcinogenesis. World J Gastroenterol. 2012; 18(37):5164-70. PMC: 3468847. DOI: 10.3748/wjg.v18.i37.5164. View

10.

Seo H, Curtiss J, Mlodzik M, Fjose A . Six class homeobox genes in drosophila belong to three distinct families and are involved in head development. Mech Dev. 1999; 83(1-2):127-39. DOI: 10.1016/s0925-4773(99)00045-3. View

11.

El-Rifai W, Sarlomo-Rikala M, Andersson L, Miettinen M, Knuutila S . High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer. 2000; 27(4):387-91. View

12.

Coletta R, Christensen K, Micalizzi D, Jedlicka P, Varella-Garcia M, Ford H . Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res. 2008; 68(7):2204-13. DOI: 10.1158/0008-5472.CAN-07-3141. View

13.

Yu Y, Davicioni E, Triche T, Merlino G . The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res. 2006; 66(4):1982-9. DOI: 10.1158/0008-5472.CAN-05-2360. View

14.

Zheng W, Huang L, Wei Z, Silvius D, Tang B, Xu P . The role of Six1 in mammalian auditory system development. Development. 2003; 130(17):3989-4000. PMC: 3873880. DOI: 10.1242/dev.00628. View

15.

Buller C, Xu X, Marquis V, Schwanke R, Xu P . Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. Hum Mol Genet. 2001; 10(24):2775-81. DOI: 10.1093/hmg/10.24.2775. View

16.

Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R . Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011; 71(23):7187-97. DOI: 10.1158/0008-5472.CAN-11-1349. View

17.

Cui J, Chen Y, Chou W, Sun L, Chen L, Suo J . An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 2010; 39(4):1197-207. PMC: 3045610. DOI: 10.1093/nar/gkq960. View

18.

Kumar J . The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci. 2008; 66(4):565-83. PMC: 2716997. DOI: 10.1007/s00018-008-8335-4. View

19.

Zou D, Silvius D, Fritzsch B, Xu P . Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes. Development. 2004; 131(22):5561-72. PMC: 3882150. DOI: 10.1242/dev.01437. View

20.

McCoy E, Iwanaga R, Jedlicka P, Abbey N, Chodosh L, Heichman K . Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest. 2009; 119(9):2663-77. PMC: 2735909. DOI: 10.1172/JCI37691. View